Cargando…

Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology

Many viruses induce hepatitis in humans, highlighting the need to understand the underlying mechanisms of virus-induced liver pathology. The murine coronavirus, mouse hepatitis virus (MHV), causes acute hepatitis in its natural host and provides a useful model for understanding virus interaction wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ling, Jha, Babal K., Wu, Ashley, Elliott, Ruth, Ziebuhr, John, Gorbalenya, Alexander E., Silverman, Robert H., Weiss, Susan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377938/
https://www.ncbi.nlm.nih.gov/pubmed/22704621
http://dx.doi.org/10.1016/j.chom.2012.04.011
_version_ 1782236008651161600
author Zhao, Ling
Jha, Babal K.
Wu, Ashley
Elliott, Ruth
Ziebuhr, John
Gorbalenya, Alexander E.
Silverman, Robert H.
Weiss, Susan R.
author_facet Zhao, Ling
Jha, Babal K.
Wu, Ashley
Elliott, Ruth
Ziebuhr, John
Gorbalenya, Alexander E.
Silverman, Robert H.
Weiss, Susan R.
author_sort Zhao, Ling
collection PubMed
description Many viruses induce hepatitis in humans, highlighting the need to understand the underlying mechanisms of virus-induced liver pathology. The murine coronavirus, mouse hepatitis virus (MHV), causes acute hepatitis in its natural host and provides a useful model for understanding virus interaction with liver cells. The MHV accessory protein, ns2, antagonizes the type I interferon response and promotes hepatitis. We show that ns2 has 2′,5′-phosphodiesterase activity, which blocks the interferon inducible 2′,5′-oligoadenylate synthetase (OAS)-RNase L pathway to facilitate hepatitis development. Ns2 cleaves 2′,5′-oligoadenylate, the product of OAS, to prevent activation of the cellular endoribonuclease RNase L and consequently block viral RNA degradation. An ns2 mutant virus was unable to replicate in the liver or induce hepatitis in wild-type mice, but was highly pathogenic in RNase L deficient mice. Thus, RNase L is a critical cellular factor for protection against viral infection of the liver and the resulting hepatitis.
format Online
Article
Text
id pubmed-3377938
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-33779382013-06-14 Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology Zhao, Ling Jha, Babal K. Wu, Ashley Elliott, Ruth Ziebuhr, John Gorbalenya, Alexander E. Silverman, Robert H. Weiss, Susan R. Cell Host Microbe Article Many viruses induce hepatitis in humans, highlighting the need to understand the underlying mechanisms of virus-induced liver pathology. The murine coronavirus, mouse hepatitis virus (MHV), causes acute hepatitis in its natural host and provides a useful model for understanding virus interaction with liver cells. The MHV accessory protein, ns2, antagonizes the type I interferon response and promotes hepatitis. We show that ns2 has 2′,5′-phosphodiesterase activity, which blocks the interferon inducible 2′,5′-oligoadenylate synthetase (OAS)-RNase L pathway to facilitate hepatitis development. Ns2 cleaves 2′,5′-oligoadenylate, the product of OAS, to prevent activation of the cellular endoribonuclease RNase L and consequently block viral RNA degradation. An ns2 mutant virus was unable to replicate in the liver or induce hepatitis in wild-type mice, but was highly pathogenic in RNase L deficient mice. Thus, RNase L is a critical cellular factor for protection against viral infection of the liver and the resulting hepatitis. Elsevier Inc. 2012-06-14 2012-06-13 /pmc/articles/PMC3377938/ /pubmed/22704621 http://dx.doi.org/10.1016/j.chom.2012.04.011 Text en Copyright © 2012 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhao, Ling
Jha, Babal K.
Wu, Ashley
Elliott, Ruth
Ziebuhr, John
Gorbalenya, Alexander E.
Silverman, Robert H.
Weiss, Susan R.
Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
title Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
title_full Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
title_fullStr Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
title_full_unstemmed Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
title_short Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
title_sort antagonism of the interferon-induced oas-rnase l pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377938/
https://www.ncbi.nlm.nih.gov/pubmed/22704621
http://dx.doi.org/10.1016/j.chom.2012.04.011
work_keys_str_mv AT zhaoling antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT jhababalk antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT wuashley antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT elliottruth antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT ziebuhrjohn antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT gorbalenyaalexandere antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT silvermanroberth antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology
AT weisssusanr antagonismoftheinterferoninducedoasrnaselpathwaybymurinecoronavirusns2proteinisrequiredforvirusreplicationandliverpathology